DR. KHOSROW MAHDAVI, MD

Plain English
This study looked at how certain brain systems affect appetite in young chickens (broilers) when influenced by a hormone called gastric inhibitory polypeptide (GIP). Researchers found that when GIP was injected in higher doses (6 and 12 nmol), the chickens ate significantly less food compared to those not receiving GIP. They also discovered that blocking specific receptors in the brain reduced the appetite-suppressing effect of GIP, suggesting that these receptors play a key role in appetite control. Who this helps: This benefits farmers and the poultry industry by potentially improving feeding strategies for broilers.

Plain English
This research paper looked at a hormone called ghrelin, which helps control appetite in birds, and how it interacts with various brain systems related to hunger. The study found that unlike in mammals, where ghrelin usually encourages eating, it can sometimes actually decrease appetite in birds. Understanding these mechanisms is important for better managing bird populations and their feeding behaviors, especially in changing environments. Who this helps: This benefits wildlife managers and conservationists working to protect bird species.

Plain English
This study looked at how a substance called LEAP2 affects how much food broiler chickens eat. Researchers found that when they injected chickens with LEAP2, those given higher doses (1.5 and 3 nmol) ate less food compared to those who didn't receive the injection. The results are important because they show that LEAP2 plays a role in regulating hunger in chickens and might interact with certain brain chemicals, affecting their food intake. Who this helps: This benefits poultry farmers and those involved in chicken production by potentially improving feed management.

Plain English
This study focused on a rare case of a patient with two types of cancer at once: chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), both affecting the bone marrow. The researchers found that diagnosing these cancers together can be challenging due to their similar features, and emphasize the need for specific testing to confirm the diagnosis accurately. This research is important because better diagnosis can lead to more effective treatment options for patients with these complex conditions. Who this helps: This helps patients with composite lymphomas and their doctors.

Plain English
This study compared two tools for assessing voice problems in patients with Parkinson's disease, CAPE-V and an AI-based tool called GRBASZero. Researchers tested 44 patients and found that CAPE-V was better at detecting voice issues at all stages of the disease, while GRBASZero only identified specific problems (breathiness and strain) in advanced cases. This matters because using the right assessment tool can lead to earlier and more effective diagnoses and treatments for voice disorders in Parkinson's patients. Who this helps: Patients with Parkinson's disease and their healthcare providers.

Plain English
This study looked at how a substance called C-type natriuretic peptide (CNP-22) affects how much young chickens (broilers) eat. The researchers found that when they injected higher doses of CNP-22, the chickens ate less; specifically, doses of 1.5 and 3 nmol led to a noticeable drop in food consumption. This is important because understanding how CNP-22 influences eating could help in managing food intake in livestock and improving their health. Who this helps: This helps farmers and poultry producers looking to optimize feeding in chickens.

Plain English
This study looked at how a protein called epidermal growth factor (EGF) affects food intake in young chickens. The researchers found that when they injected EGF into the brains of five-day-old male broilers, it significantly reduced the amount of food they ate; specifically, doses of 100 and 200 ng cut food consumption compared to controls. This discovery is important because it shows for the first time that EGF can suppress appetite in chickens, which could help improve feed efficiency in poultry farming. Who this helps: This helps poultry farmers and the agriculture industry by potentially improving growth rates and feed efficiency in chickens.

Plain English
This study looked at how certain brain chemicals, called neurotransmitters, affect the eating habits of two types of chickens: broilers (raised for meat) and layers (raised for eggs). The researchers found that while many neurotransmitters have similar effects on both types of chickens, some—like dopamine and ghrelin—show different effects. Understanding these differences matters because it can help improve chicken breeding practices for better food production. Who this helps: This helps poultry farmers and researchers working on chicken production.

Plain English
This study looked at a drug called NE3107, which is designed to reduce inflammation and improve insulin sensitivity, in patients with mild dementia and mild cognitive impairment. After three months of treatment, improvements were seen in cognitive tests: participants had statistically significant better scores in several assessments, including an 11-item test for Alzheimer’s disease (with a P-value of 0.017), and also showed beneficial changes in brain biomarkers related to Alzheimer's (like P-tau levels, P=0.034). This is important because it suggests that reducing inflammation may help slow down cognitive decline in people with dementia. Who this helps: This research benefits patients with mild dementia and mild cognitive impairment and their caregivers.

Plain English
This study looked at how well a new treatment called Nowarta110 works against certain types of cervical cancer caused by the human papillomavirus (HPV), specifically HPV-16 and HPV-18. Researchers found that Nowarta110 can kill cancer cells in the lab, with complete cell death at a 5% concentration, and it also shrank tumors in mice models. This is important because cervical cancer is a major health issue, and new effective treatments are desperately needed. Who this helps: This benefits patients suffering from cervical cancer and doctors looking for effective treatment options.

Plain English
This study tested a new treatment called Nowarta110 on mice with melanoma, a serious skin cancer. They found that mice treated with Nowarta110 had significantly smaller tumors after five weeks compared to untreated mice, indicating that the treatment was effective. Specifically, while untreated mice had tumors that continued to grow, Nowarta110 reduced tumor size significantly, especially in mice with healthy immune systems. Who this helps: This research benefits patients with melanoma and other skin cancers by potentially leading to new treatment options.

Plain English
This study examined how well ketamine can reduce anxiety symptoms over time in various medical situations. Researchers found that ketamine significantly lowered anxiety levels compared to a placebo within the first 12 hours and continued to show relief at 24 hours and up to 14 days later, with a substantial reduction in anxiety scores (about 1.17 points within the first 12 hours and around 0.40 points after one to two weeks). Understanding how quickly and effectively ketamine works is important for developing better treatments for anxiety disorders. Who this helps: This benefits patients suffering from anxiety disorders.

Plain English
This research paper looks at how certain chemicals in the brain, called opioids, affect how birds and mammals eat. It finds that these opioids play an important role in appetite control, particularly through specific receptors in the brain. Understanding this can help develop better treatments for obesity and improve health for both animals and humans. Who this helps: This helps patients struggling with obesity and healthcare providers looking for effective treatments.

Plain English
This study explored how a substance called apelin-13 affects the eating behavior of young chickens by looking at its interaction with specific receptors in their bodies. The researchers found that when the chickens received injections of apelin-13, their food intake decreased significantly, especially at doses of 0.5 and 1 microgram, leading to a state known as hypophagia. This reduced appetite was influenced by other substances that block certain receptors, highlighting the complex interactions between these pathways in regulating food intake and activity. Who this helps: This research aids poultry farmers and veterinarians in understanding feeding behaviors in chickens, potentially leading to better management practices.

Plain English
This study looked at how to effectively locate a specific area of the brain, the dorsolateral prefrontal cortex (dlPFC), which is important for brain treatments like transcranial magnetic stimulation (TMS). The researchers found that, surprisingly, about 21% of right-handed participants had their dominant dlPFC in the right hemisphere, rather than the usual left hemisphere, while 17% of left-handed individuals showed dominance in their left hemisphere. This matters because identifying the correct side of the brain to target can improve the safety and effectiveness of treatments for various conditions. Who this helps: This helps patients undergoing brain treatments, like TMS.

Plain English
This study looked at using low-power ultrasound to help deliver tiny particles from stem cells to the brain, overcoming a barrier that usually prevents drugs from entering. Researchers found that after 60 minutes of ultrasound treatment, there was more concentration of these particles in a specific brain area called the hippocampus, suggesting that the method could enhance delivery of beneficial substances. However, the ultrasound did not open the blood-brain barrier as hoped, which is important for considering how we can improve treatments for brain conditions. Who this helps: This benefits researchers and healthcare providers looking for better ways to deliver therapies to the brain.

Plain English
This study looked at how a substance called neuropeptide W (NPW) affects how much food neonatal meat-type chicks eat and their feeding behavior. The researchers found that when they infused NPW into the chicks, specifically doses of 1.5 and 3 nmol, it significantly increased their food intake. Additionally, using certain blockers alongside NPW enhanced or reduced its appetite-boosting effects, indicating that various receptors in the chicks' bodies play a role in this process. Who this helps: This research benefits poultry farmers and veterinarians by improving understanding of feeding behaviors in broiler chicks.

Plain English
This study focuses on creating a new type of material that can break down toxic pollutants using light, known as a photocatalyst. The researchers developed a nanocomposite that can effectively remove contaminants like erythrosine, achieving a high degradation rate of 92.9%. This matters because it shows a promising way to clean up harmful substances from the environment quickly and efficiently. Who this helps: This benefits environmental scientists and organizations working to reduce pollution.

Plain English
This study looked at how effective platelet rich plasma (PRP) therapy is for treating chronic lower back pain caused by disc issues. Out of 26 participants, only 17% of those receiving PRP reported significant pain relief, compared to 13% in the placebo group, highlighting that the benefits seen in previous research might not be replicable. This matters because it raises questions about the reliability of PRP as a treatment and suggests that more research is needed before it can be widely recommended. Who this helps: This helps patients suffering from chronic lower back pain and their doctors in making informed treatment decisions.

Plain English
This study looked at two military service members with PTSD, one showing classic symptoms and the other experiencing dissociative symptoms. It found that their brain activity in the insula was different: the person with classic PTSD had activity in the front part of the insula, while the dissociative patient showed activity in the back part. These findings highlight that different types of PTSD may be rooted in distinct brain functions, which can help in developing better treatment strategies. Who this helps: This helps patients with PTSD and the doctors treating them.

Plain English
This study looked at how the hormone ghrelin affects food intake in laying chickens and whether certain opioid receptors play a role in this process. Researchers found that while a low dose of ghrelin did not change how much the chickens ate, higher doses of 3 and 6 nmol significantly reduced their food intake. The data suggests that the opioid μ receptor is involved in this effect, as it showed increased activity, while other opioid receptors did not change. Who this helps: This research benefits poultry farmers by improving understanding of factors that influence chicken feeding behavior.

Plain English
This study looked at the effects of a supplement called DHA-AAG on people with cognitive impairments. Over four months, the participants took increasing doses of 900 to 3,600 mg daily, leading to higher levels of DHA plasmalogens in their blood and improvements in mobility for 12 out of 22 participants. The study found that DHA-AAG was safe, well-tolerated, and provided some cognitive benefits, even though individual responses varied. Who this helps: This helps patients with cognitive impairments looking for ways to improve their brain function and mobility.

Plain English
This study looked at a 29-year-old military woman with trauma-related symptoms, including tremors and seizures. After 36 sessions of a treatment called repetitive transcranial magnetic stimulation (rTMS) aimed at specific brain areas, her symptoms improved enough for her to return to active duty. This matters because it shows that targeting brain activity can effectively help people with complex trauma-related disorders. Who this helps: Patients with dissociative PTSD and related symptoms.

Plain English
This study looked at a new type of hydroxyapatite (HA) nanopowder, which was modified by adding several different ions to improve its effectiveness in medical applications. The researchers found that this new nanopowder, called SHA, showed better characteristics than regular HA, including a change in shape that resembles natural bone and increased activity promoting cell growth. Specifically, SHA nanoparticles enhanced cell attachment and growth, making them a promising option for use in bone implants and orthopedic treatments. Who this helps: This benefits patients needing bone implants or treatments for bone-related issues.

Plain English
Researchers studied a new treatment using focused ultrasound to help patients with Alzheimer's disease and Parkinson's disease by targeting specific areas of the brain. They treated 22 patients over eight weeks and found that 62.5% had improved scores on cognitive tests, and 87% saw stable or better results in both fine and gross motor skills, with no reported side effects. This matters because it offers a potential safe treatment option that may enhance the quality of life for patients with these neurodegenerative conditions. Who this helps: Patients with Alzheimer's and Parkinson's diseases.

Plain English
This study looked at how different types of vaccines help patients with metastatic melanoma, a serious skin cancer that has spread. Researchers found that patients who received a vaccine made from their own dendritic cells and tumor cells had much better survival rates than those who received a vaccine made from just tumor cells. Specifically, the median survival time for those on the dendritic cell vaccine was 60 months compared to just 22 months for the others, and after five years, 51% of dendritic cell patients were still alive compared to only 32% of tumor cell patients. Who this helps: This research benefits patients with metastatic melanoma by providing insights into more effective treatment options.

Plain English
This study looked at whether ultrasound could effectively determine the normal position of a section of the intestine in newborns and infants, which helps identify a condition called malrotation. Researchers examined 60 babies and found that ultrasound clearly showed the normal positioning in all cases, taking an average of about 48 seconds to do so. This is important because using ultrasound can quickly and accurately confirm the correct position, avoiding more invasive and potentially unnecessary tests like barium studies. Who this helps: This benefits newborns and infants who may be at risk for intestinal issues, as well as their doctors looking for efficient diagnostic methods.

Plain English
This study looked at how common vitamin D deficiency is among patients with acute coronary syndrome (a serious heart condition) compared to healthy individuals. They found that 72% of the heart patients had low vitamin D levels (20 ng/ml or less), while only 27.4% of the healthy group had the same deficiency. Although most heart patients had low vitamin D, this deficiency didn't seem to affect their short-term risk of dying after being admitted to the hospital. Who this helps: This helps patients with heart conditions and their doctors understand the importance of monitoring vitamin D levels.

Plain English
This study looked at the long-term effects of a treatment called interleukin-2 (IL2) for patients with advanced melanoma. Among 150 patients treated with IL2, the average survival was 15.6 months, with 20% living for at least five years. Even though new treatments are available, IL2 may still be the best option for many healthy patients with this aggressive cancer. Who this helps: This helps patients with metastatic melanoma and their doctors in choosing the best treatment options.

Plain English
The study focused on the effectiveness of a specialized chest pain unit in an emergency department at Imam Khomeini Hospital in Iran. Researchers found that in 2010, 43% of patients were discharged after evaluation in this unit compared to 26% in 2007, while fewer patients chose to leave against medical advice, dropping from 37% to 14%. This matters because it shows that having a dedicated chest pain unit can lead to better patient care by reducing unnecessary hospital stays and increasing patient satisfaction. Who this helps: This benefits patients experiencing chest pain and emergency department staff.

Plain English
This study looked at a combination treatment for advanced kidney cancer, using a shot of interferon followed by intravenous doses of interleukin-2. Out of 36 patients, only 4 (11%) had a notable reduction in their tumors, while 40% had stable disease; overall, patients lived an average of 15 months after starting treatment, with survival rates of 53% at one year and 12% at five years. These results are comparable to other studies using high-dose interleukin-2, meaning this treatment could be a viable option for kidney cancer patients. Who this helps: Patients with metastatic renal cell carcinoma.

Plain English
This study looked at a personalized vaccine made from the patient's own tumor cells to treat advanced kidney cancer in 25 patients. The results showed that while the vaccine was safe and well-tolerated, it did not lead to any significant decreases in tumors, with no objective responses among patients with detectable disease. On average, patients lived for about 33.4 months, and 43% were still alive five years after starting treatment, but the treatment did not show a clear benefit in fighting the cancer. Who this helps: This research helps doctors and researchers understand the limits of this treatment strategy for kidney cancer.

Plain English
This study explored the use of vaccines made from patients' own kidney tumors to treat kidney cancer. Researchers successfully created tumor cell cultures from 80% of the samples collected, and 27 patients received vaccine treatments. Among those who were free of cancer when treated, 90% survived for one to eight years, while patients with existing metastatic disease had a median survival of only 5 months, with limited positive responses to the treatment. Who this helps: This research benefits kidney cancer patients, particularly those in remission, by offering a potentially effective treatment option.

Plain English
This study examined the effects of combining a drug called interferon-alpha2a and another drug, cis-retinoic acid, with radiation therapy in patients with high-grade brain tumors, known as gliomas. In the trial, 40 patients underwent this treatment, but the results showed no significant improvement in survival compared to similar past treatments; the average survival time was about 9.3 months and 42% were alive after one year. This is important because it indicates that adding these drugs to radiation therapy does not enhance survival for patients with high-grade gliomas. Who this helps: This research helps patients with high-grade gliomas and their doctors by providing clarity on treatment options.

Plain English
This study looked at whether it's possible to create vaccines from ovarian cancer cells taken from patients after surgery and chemotherapy. Researchers successfully grew tumor cell cultures from 37% of the samples they collected—21 out of 57—which included samples from patients at different stages of their cancer. This matters because these vaccines could provide a new treatment option to help the immune system fight the cancer more effectively. Who this helps: This helps patients with advanced ovarian cancer.

Plain English
This research studied patients with advanced cancer who received a combination of high-dose chemotherapy and their own stem cells to help recover from treatment. Over five years, 75 patients were treated and showed improvements: the median survival increased from eight months in the first year to 30.4 months overall, and 57% of patients were free from cancer after one year. This matters because it demonstrates that using stem cell rescue alongside intense chemotherapy can lead to better outcomes and fewer deaths shortly after treatment. Who this helps: This benefits cancer patients, especially those with metastatic breast cancer and recurrent lymphoma.

Plain English
This study looked at how a special enzyme called Q beta replicase can rapidly make copies of certain RNA molecules, producing up to 100 trillion copies in just a few minutes. Researchers found that Q beta replicase can create RNA without needing a template, and in relaxed conditions, spontaneous RNA production occurred in 100% of tests. The significance of this is that understanding how this process works can improve techniques for amplifying RNA in labs, which is important for various biological studies. Who this helps: This helps researchers and scientists working in molecular biology and RNA studies.